Acne 

Actinic Keratosis 

Aesthetics

Alopecia

Biologic Treatments for Moderate to Severe Atopic Dermatitis 

Atopic Dermatitis 

Buy-and-Bill

COVID-19

Case-Based Roundtable

Chronic Hand Eczema

Drug Watch

Eczema

General Dermatology 

Hidradenitis Suppurativa

Melasma

NP and PA

Pediatric Dermatology

Pigmentary Disorders 

Practice Management 

Precision Medicine and Biologics

Prurigo Nodularis

Emerging Therapies Plaque Psoriasis

Treatments for Plaque Psoriasis 

Psoriasis 

Psoriatic Arthritis 

Rare Disease

Rosacea 

Skin Cancer (Nonmelanoma)

Skin Cancer

Vitiligo

Wound Care

News

Media

Around the Practice

Between The Lines

Case-Based Peer Perspective

Clinical Case Collective

DermView

Expert Perspectives

Fellows Face Off

Frontline Forum

Medical World News

Patient Perspectives

Podcasts

Readout360

Recognize and Refer

Conferences

Conference Coverage

Conference Listing

Events

Publication

Dermatology Times

CME/CE

Resources

DermIQ

Interactive Tools

Job Board

Partner Perspectives

Perspectives in Dermatology

Polls

Editorial Advisory Board

Partners

Subscribe

and joined the MJH Life Sciences team in February 2023. She attended Kent State University and earned a Bachelor of Science degree in journalism with minors in public relations and creative writing. She enjoys making and listening to music, reading, and spending time with her cats, Astrid and Marceline.

Articles

Catch up on dermatology news, highlights, and insights from the past 24 hours.

Daily Derm Times: March 27, 2025

Xyngari showed promise as the first once-weekly topical acne treatment, achieving strong phase 3 results with significant efficacy and safety.

Topical Xyngari Meets All Primary Endpoints in Phase 3 Study for Moderate to Severe Acne

Maddi Hebebrand is an associate editor of 

and joined the MJH Life Sciences team in May 2024. She attended Baldwin Wallace University, studying Media Production and Film, and is now finishing her Masters in Digital Media through Ohio University. When she's not writing, Maddi loves to read, attend concerts and spend time with her family.

The cream contains barrier-repairing ingredients that may enhance self-healing and hydration in affected skin.

Can BSZY Cream Reduce Symptoms of Facial Atopic Dermatitis?

Marie Bosslett is the assistant editor of 

 and joined the MJH Life Sciences team in October 2024. She attended Loyola University Maryland in Baltimore and earned a Bachelor of Arts in Communication with minors in marketing and writing. When she’s not writing, Marie enjoys going to concerts, reading on the beach, and spending time with friends and family.

In a prospective study, patients with scalp seborrheic dermatitis saw positive results in efficacy, safety, and quality of life when using the AgNP product.

Novel Synthesized Silver Nanoparticle Shampoo is Comparable to 2% Ketoconazole for SD Treatment 

About

Advertise

Contact Us

Do Not Sell My Information

Terms and Conditions

Privacy Policy

Dermatology Times and Multimedia Medical, LLC

Facebook

Linkedin

Topics

Acne

Pigmentary Disorders

Practice Management

Psoriasis

Psoriatic Arthritis

Rosacea

Clinical Case Collective 

Aaron Farberg, MD; Tina Bhutani, MD, MAS; Christopher Bunick, MD, PhD; and Harrison Nguyen, MD, MBA, MPH, explore the complex challenges of identifying, treating, and managing generalized pustular psoriasis—a rare, potentially life-threatening condition characterized by widespread sterile pustules—discussing its profound quality-of-life impact, common triggers, evolution of treatments from traditional systemics to targeted biologics, clinical cases highlighting emergency management and maintenance approaches, and promising future directions in diagnostics and personalized therapies.

Navigating the Complexities of Generalized Pustular Psoriasis Diagnosis and Management

Lisa Swanson, MD; Linda Stein Gold, MD; James Song, MD, and James Del Rosso, DO, examine comprehensive approaches to managing moderate to severe atopic dermatitis, with particular focus on JAK inhibitor therapy selection, safety monitoring, and clinical decision-making through detailed analysis of patient cases, therapeutic advances, and emerging research.

Assessing the Use of JAK Inhibitors in Atopic Dermatitis Management

Alexa Hetzel, MS, PA-C; Andrew Mastro, MS, PA-C; TJ Chao, MPAS, PA-C, and Terry Faleye, MPAS, PA-C, explore plaque psoriasis through patient case analyses and treatment paradigm evaluations, identifying potential areas for advancement in care.

Plaque Psoriasis Management: Evaluating Non-Steroidal Treatments and Current Data Trends